Jose Baselga (José Baselga)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 6

Top Topics

Endoplasmic Reticulum

Positive Breast Cancer

Tyrosine Kinase

Top Venues

Science (New York, N.Y.)

Science signaling

Nature genetics

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Guotai Xu, Sagar Chhangawala, Emiliano Cocco, Pedram Razavi, Yanyan Cai, Jordan E Otto, Lorenzo Ferrando, Pier Selenica, Erik Ladewig, Carmen Chan, Arnaud Da Cruz Paula, Matthew Witkin, Yuanming Cheng, Jane Park, Cristian Serna-Tamayo, HuiYong Zhao, Fan Wu, Mirna Sallaku, Xuan Qu, Alison Zhao, Clayton K Collings, Andrew R D'Avino, Komal Jhaveri, Richard P Koche, Ross L Levine, Jorge Sergio Reis-Filho, Cigall Kadoch, Maurizio Scaltriti, Christina S Leslie, Jose Baselga, Eneda Toska
ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer. Nature genetics 52 (2) (2020)
Mark J Roschewski, Michail S Lionakis, Jeff P Sharman, Joseph Roswarski, Andre Goy, M Andrew Monticelli, Michael Roshon, Stephen H Wrzesinski, Jigar V Desai, Marissa A Zarakas, Jacob Collen, Keith Rose, Ahmed Hamdy, Raquel Izumi, George W Wright, Kevin K Chung, Jose Baselga, Louis M Staudt, Wyndham H Wilson
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Science immunology 5 (48) (2020)
Neil Vasan, Pedram Razavi, Jared L Johnson, Hong Shao, Hardik Shah, Alesia Antoine, Erik Ladewig, Alexander N Gorelick, Ting-Yu Lin, Eneda Toska, Guotai Xu, Abiha Kazmi, Matthew T Chang, Barry S Taylor, Maura N Dickler, Komal Jhaveri, Sarat Chandarlapaty, Raúl Rabadán, Ed Reznik, Melissa Laird Smith, Robert Sebra, Frauke Schimmoller, Timothy R Wilson, Lori S Friedman, Lewis C Cantley, Maurizio Scaltriti, Jose Baselga
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors. Science (New York, N.Y.) 366 (6466) (2020)
Irene Rius Ruiz, Rocio Vicario, Beatriz Morancho, Cristina Bernadó Morales, Enrique J Arenas Lahuerta, Sylvia Herter, Anne Freimoser-Grundschober, Jitka Somandin, Johannes Sam, Oliver Ast, Águeda Martinez Barriocanal, Antonio Luque, Marta Escorihuela, Ismael Varela, Isabel Cuartas, Paolo G Nuciforo, Roberta Fasani, Vicente Peg, Isabel Rubio, Javier Cortes, Violeta Serra, Santiago Escriva-de-Romani, Jeff Sperinde, Ahmed Chenna, Weidong Huang, John Winslow, Joan Albanell, Joan Seoane, Maurizio Scaltriti, Jose Baselga, Josep Tabernero, Pablo Umana, Marina Bacac, Cristina Saura, Christiane Neumann, Joaquín Arribas
p95HER2-T cell bispecific antibody for breast cancer treatment. Science translational medicine 10 (461) (2019)
Emiliano Cocco, F Javier Carmona, Pedram Razavi, Helen H Won, Yanyan Cai, Valentina Rossi, Carmen Chan, James Cownie, Joanne Soong, Eneda Toska, Sophie G Shifman, Ivana Sarotto, Peter Savas, Michael J Wick, Kyriakos P Papadopoulos, Alyssa Moriarty, Richard E Cutler, Francesca Avogadri-Connors, Alshad S Lalani, Richard P Bryce, Sarat Chandarlapaty, David M Hyman, David B Solit, Valentina Boni, Sherene Loi, Jose Baselga, Michael F Berger, Filippo Montemurro, Maurizio Scaltriti
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2). Science signaling 11 (551) (2018)
Eneda Toska, Hatice U Osmanbeyoglu, Hatice Ulku Osmanbeyoglu, Carmen Chan, Ronald C Hendrickson, Moshe Elkabets, Maura N Dickler, Maurizio Scaltriti, Christina S Leslie, Scott A Armstrong, Jose Baselga
PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D. Science (New York, N.Y.) 355 (6331) (2017)